Related Experiment Videos
[Gestonorone therapy of prostatic adenoma]
Acta Chirurgica Academiae Scientiarum Hungaricae
|January 1, 1980
Abstract:
Clinical trials with gestonorone led to favourable results in 65% of the patients. The drug is recommended particularly to patients in stage I or II of prostatic adenoma. It is justified to prescribe this treatment to high risk patients who cannot be operated because of their serious conditions. An objective assessment of the effect of the drug was possible by means of urodynamic and ultrasound tests which detected also fewer latent changes suggesting a continuation or repetition of the treatment.